[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Scheidweiler KB, Newmeyer MN, Barnes AJ, Huestis MA
You should not take a GLP-1 drug if you have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis or a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis
It is FDA-approved for Type 2 diabetes but is sometimes prescribed off-label for weight loss
GLP-1 receptors exist throughout the vascular system, and their activation may alter autoregulation of blood flow to the optic nerve head, particularly during nocturnal blood pressure dips when many NAION events occur
Our goal is healthier body composition, better energy, improved metabolic health and sustainable long-term results